flubendazole has been researched along with Melanoma in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Corley, S; Hossain, MJ; Khachigian, LM; Li, Y; O'Meara, C; Quagliata, L; Wilkins, MR; Wu, B | 1 |
Rudolf, E; Rudolf, K | 1 |
Čáňová, K; Rozkydalová, L; Rudolf, E; Vokurková, D | 1 |
Acharya, G; Elahy, M; Khachigian, LM; Li, Y; Xin, H | 1 |
4 other study(ies) available for flubendazole and Melanoma
Article | Year |
---|---|
Flubendazole inhibits PD-1 and suppresses melanoma growth in immunocompetent mice.
Topics: Animals; B7-H1 Antigen; Cell Line, Tumor; Humans; Melanoma; Mice; Mice, Inbred C57BL; Programmed Cell Death 1 Receptor; Skin Neoplasms; Transcription Factor AP-1 | 2023 |
An analysis of mitotic catastrophe induced cell responses in melanoma cells exposed to flubendazole.
Topics: Aged; Antineoplastic Agents; Apoptosis; Autophagy; Cell Cycle; Cell Line, Tumor; Cytochromes c; Humans; JNK Mitogen-Activated Protein Kinases; Male; Mebendazole; Melanoma; Membrane Potential, Mitochondrial; Middle Aged; Mitosis; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53 | 2020 |
Flubendazole induces mitotic catastrophe and apoptosis in melanoma cells.
Topics: Antinematodal Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Humans; Mebendazole; Melanoma; Mitosis | 2018 |
The anthelmintic flubendazole blocks human melanoma growth and metastasis and suppresses programmed cell death protein-1 and myeloid-derived suppressor cell accumulation.
Topics: Animals; Antinematodal Agents; Antineoplastic Agents; Cell Growth Processes; Cell Line, Tumor; Female; Humans; Lung Neoplasms; Mebendazole; Melanoma; Mice; Mice, SCID; Myeloid-Derived Suppressor Cells; Neoplasm Metastasis; Neovascularization, Pathologic; Programmed Cell Death 1 Receptor; Random Allocation; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2019 |